Close Menu

hepatitis

Several companies will receive grants to develop hepatitis C molecular point-of-care and core antigen diagnostic assays.

The new assay simultaneously detects four viral targets in donated blood plasma in a single sample and can add value to the biologics development space.

Independent research teams identified and sequenced hepatitis B strains going back thousands of years from samples in Europe, uncovering now-extinct lineages.

The companies will initially plan to acquire the required regulatory approvals in India for the Genedrive HCV ID kit.

The firm noted that the premarket approval means that the three major viral load assays that most laboratories run for patients are now available on a single system.

While the virus they found appears old, the researchers found it to be closely related to modern ones, indicating that it has infected people for centuries.

The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.

Medcis Pathlabs and its associates and attendees will buy Co-Diagnostics' tests for hepatitis B, hepatitis C, HIV, and human papillomavirus.

The test adds to the firm's current portfolio of 30 infectious disease and oncology tests that use its Sentosa PCR and NGS workflow.

Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.

Pages

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.